TW470647B - Composition and pharmaceutical combination kit comprising formoterol and budesonide - Google Patents

Composition and pharmaceutical combination kit comprising formoterol and budesonide Download PDF

Info

Publication number
TW470647B
TW470647B TW086114371A TW86114371A TW470647B TW 470647 B TW470647 B TW 470647B TW 086114371 A TW086114371 A TW 086114371A TW 86114371 A TW86114371 A TW 86114371A TW 470647 B TW470647 B TW 470647B
Authority
TW
Taiwan
Prior art keywords
active ingredient
patent application
budesonide
composition
scope
Prior art date
Application number
TW086114371A
Other languages
English (en)
Chinese (zh)
Inventor
Jan Trofast
Anders Ullman
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of TW470647B publication Critical patent/TW470647B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
TW086114371A 1996-10-08 1997-10-02 Composition and pharmaceutical combination kit comprising formoterol and budesonide TW470647B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9603669A SE9603669D0 (sv) 1996-10-08 1996-10-08 New combination

Publications (1)

Publication Number Publication Date
TW470647B true TW470647B (en) 2002-01-01

Family

ID=20404167

Family Applications (1)

Application Number Title Priority Date Filing Date
TW086114371A TW470647B (en) 1996-10-08 1997-10-02 Composition and pharmaceutical combination kit comprising formoterol and budesonide

Country Status (18)

Country Link
EP (1) EP0871450A1 (no)
JP (1) JP2000502365A (no)
KR (1) KR19990071975A (no)
AR (1) AR013614A1 (no)
AU (1) AU715319B2 (no)
BR (1) BR9706822A (no)
CA (1) CA2239308A1 (no)
CZ (1) CZ176198A3 (no)
HU (1) HUP9901674A3 (no)
MY (1) MY128337A (no)
NO (1) NO982414D0 (no)
NZ (1) NZ330482A (no)
PL (1) PL327037A1 (no)
SE (1) SE9603669D0 (no)
SK (1) SK75198A3 (no)
TW (1) TW470647B (no)
WO (1) WO1998015280A1 (no)
ZA (1) ZA978889B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
SE9700136D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700134D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
BR9810452A (pt) * 1997-06-27 2000-09-05 Astra Ab Nova combinação de medicamentos contra asma
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
SE9900834D0 (sv) * 1999-03-09 1999-03-09 Astra Ab Novel combination
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
FI20002216A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
SE0200312D0 (sv) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
SE527069C2 (sv) 2003-06-19 2005-12-13 Mederio Ag Förfarande och anordning för administrering av läkemedelspulver
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050026887A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a steroid
JP5508003B2 (ja) 2006-06-30 2014-05-28 アイスイティカ ピーティーワイ リミテッド ナノ粒子状の形態における生物学的に活性な化合物の調製のための方法
MX2009008794A (es) 2007-02-19 2009-08-25 Cipla Ltd Combinaciones farmaceuticas al menos de dos broncodilatadores o de un broncodilatador con un corticosteroide.
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US9463161B2 (en) 2009-05-29 2016-10-11 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and associated methods and systems
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
EP2819645A2 (en) * 2012-02-28 2015-01-07 Iceutica Holdings Inc. Bvi Inhalable pharmaceutical compositions
ITMI20130571A1 (it) 2013-04-10 2014-10-11 Zambon Spa Composizione farmaceutica contenente budesonide e formoterolo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3342484B2 (ja) * 1991-12-18 2002-11-11 アストラ・アクチエボラーグ 新規な配合

Also Published As

Publication number Publication date
KR19990071975A (ko) 1999-09-27
MY128337A (en) 2007-01-31
EP0871450A1 (en) 1998-10-21
CA2239308A1 (en) 1998-04-16
AU4578297A (en) 1998-05-05
PL327037A1 (en) 1998-11-09
HUP9901674A3 (en) 2001-04-28
NO982414L (no) 1998-05-27
AU715319B2 (en) 2000-01-20
SE9603669D0 (sv) 1996-10-08
WO1998015280A1 (en) 1998-04-16
CZ176198A3 (cs) 1998-09-16
ZA978889B (en) 1998-04-08
AR013614A1 (es) 2001-01-10
NZ330482A (en) 1999-11-29
JP2000502365A (ja) 2000-02-29
NO982414D0 (no) 1998-05-27
HUP9901674A2 (hu) 1999-09-28
SK75198A3 (en) 1998-11-04
BR9706822A (pt) 1999-03-23

Similar Documents

Publication Publication Date Title
TW470647B (en) Composition and pharmaceutical combination kit comprising formoterol and budesonide
JP3342484B2 (ja) 新規な配合
TWI252756B (en) Use of a composition comprising formoterol and budesonide for the manufacture of a medicament for the treatment of asthma when needed
KR100234864B1 (ko) 기도 및 폐질환을 치료하기 위한 모메타손푸로에이트 약제
CA2302700C (en) New use for budesonide and formoterol
AU777827B2 (en) Aerosol formulations and devices for increasing libido in women via acute testosterone administration
JPH03167120A (ja) 呼吸疾患治療薬
EA023839B1 (ru) Комбинации антагониста мускариновых рецепторов и агониста бета-2-адренорецепторов
JPH03167119A (ja) 呼吸疾患治療薬
WO2000053187A1 (en) New combination of formoterol and mometasone in a pharmaceutical composition for treating respiratory disorders, such as asthma, rhinitis and copd
MXPA06008240A (es) Metodos de tratamiento.
US20100136121A1 (en) Medicaments
JP2002510310A (ja) 抗喘息薬の新規配合
TWI495466B (zh) 用於氣喘之吸入性複方組合物
JP2002527351A (ja) 気道感染に関連した風邪及びインフルエンザ様症状の予防及び治療用組成物
EP1749531B1 (en) Use of an oral suspension comprising megestrol acetate for the treatment of bronchial asthma
MXPA98004357A (en) New combination
EP1175204A1 (en) Aerosol formulations and devices for increasing libido in women via acute testosterone administration
MXPA99011676A (en) New combination of antiasthma medicaments
MXPA00011806A (en) Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MM4A Annulment or lapse of patent due to non-payment of fees